2024. In silico Study of New Five-Membered Heterocyclic Derivatives Bearing (1,3,4-oxadiazole and 1,3,4-thiadiazole) As Promising Cyclooxygenase Inhibitors. Al Mustansiriyah Journal of Pharmaceutical Sciences. 24, 3 (Jul. 2024), 237–251. DOI:https://doi.org/10.32947/ajps.v24i3.1060.